Current treatments for oropharyngeal squamous cell carcinoma and the move towards molecular therapy.
Mitra ElmiJoshua H DassCrispin R DassPublished in: The Journal of pharmacy and pharmacology (2024)
Molecular therapy is largely at the preclinical stage, with cetuximab, nivolumab, pembrolizumab, Lenvatinib, and bevacizumab being tested clinically currently.